Treatment of Fabry disease: outcome of a comparative trial with agalsidase alfa or beta at a dose of 0.2 mg/kg (Q21004071)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Treatment of Fabry disease: outcome of a comparative trial with agalsidase alfa or beta at a dose of 0.2 mg/kg |
scientific article |
Statements
Treatment of Fabry disease: outcome of a comparative trial with agalsidase alfa or beta at a dose of 0.2 mg/kg (English)
0 references
Anouk C Vedder
Gabor E Linthorst
Gunnar Houge
Johannna E M Groener
Els E Ormel
Berto J Bouma
Johannes M F G Aerts
Asle Hirth
Carla E M Hollak
2007
0 references
2
0 references
e598
0 references
7
0 references
11 July 2007
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference